N S Kenyon
Overview
Explore the profile of N S Kenyon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lanzoni G, Linetsky E, Correa D, Alvarez R, Marttos A, Hirani K, et al.
CellR4 Repair Replace Regen Reprogram
. 2021 Jun;
8.
PMID: 34164564
The coronavirus SARS-CoV-2 is cause of a global pandemic of a pneumonia-like disease termed Coronavirus Disease 2019 (COVID-19). COVID-19 presents a high mortality rate, estimated at 3.4%. More than 1...
2.
Safley S, Kenyon N, Berman D, Barber G, Cui H, Duncanson S, et al.
Eur Rev Med Pharmacol Sci
. 2020 Sep;
24(16):8551-8565.
PMID: 32894560
Objective: Our goal was to assess the efficacy of encapsulated allogeneic islets transplanted in diabetic NOD mice and streptozotocin (STZ)-diabetic nonhuman primates (NHPs). Materials And Methods: Murine or NHP islets...
3.
Han D, Xu X, Alejandro R, Ricordi C, Kenyon N
Cell Transplant
. 2017 Aug;
10(6):545-549.
PMID: 28853907
No abstract available.
4.
Han D, Cai X, Wen J, Matheson D, Skyler J, Kenyon N, et al.
Clin Exp Immunol
. 2012 Oct;
170(2):131-8.
PMID: 23039883
The mRNA levels of a set of immune-related genes were analysed with peripheral blood samples from at-risk, new-onset and long-term type 1 diabetes (T1D) patients, in comparison to those from...
5.
6.
Perez V, Caicedo A, Berman D, Arrieta E, Abdulreda M, Rodriguez-Diaz R, et al.
Diabetologia
. 2011 Mar;
54(5):1121-6.
PMID: 21360190
Aims/hypothesis: The aim of this study was to provide evidence that the anterior chamber of the eye serves as a novel clinical islet implantation site. Methods: In a preclinical model,...
7.
Buchwald P, Bocca N, Marzorati S, Hochhaus G, Bodor N, Stabler C, et al.
Pharmazie
. 2010 Jul;
65(6):421-8.
PMID: 20614690
Emerging biotechnologies, such as the use of biohybrid devices for cellular therapies, are showing increasing therapeutic promise for the treatment of various diseases, including type 1 diabetes mellitus. The functionality...
8.
Mineo D, Ricordi C, Xu X, Pileggi A, Garcia-Morales R, Khan A, et al.
Am J Transplant
. 2008 May;
8(6):1262-74.
PMID: 18444924
To prevent graft rejection and avoid immunosuppression-related side-effects, we attempted to induce recipient chimerism and graft tolerance in islet transplantation by donor CD34+hematopoietic stem cell (HSC) infusion. Six patients with...
9.
Boker A, Rothenberg L, Hernandez C, Kenyon N, Ricordi C, Alejandro R
World J Surg
. 2001 May;
25(4):481-6.
PMID: 11344402
New hope for the treatment of type 1 diabetes has recently emerged from the encouraging results of islet cell transplantation in humans during the last few years. Although still facing...
10.
Molano R, Berney T, Li H, Cattan P, Pileggi A, Vizzardelli C, et al.
Diabetes
. 2001 Mar;
50(2):270-6.
PMID: 11272136
Allorejection and recurrence of autoimmunity are the major barriers to transplantation of islets of Langerhans for the cure of type 1 diabetes in humans. CD40-CD154 (CD40 ligand) interaction blockade by...